Verastem, Inc. financial data

Symbol
VSTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
117 Kendrick Street, Suite 500, Needham, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q4 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 641 % +31.6%
Debt-to-equity 108 % +2.11%
Return On Equity -158 % -7.3%
Return On Assets -65.8 % +3.06%
Operating Margin -1.76 K % -3916%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.3 M shares -87.4%
Common Stock, Shares, Outstanding 25.3 M shares -87.4%
Entity Public Float 187 M USD
Common Stock, Value, Issued 3 K USD -85%
Weighted Average Number of Shares Outstanding, Basic 26.8 M shares +60.5%
Weighted Average Number of Shares Outstanding, Diluted 201 M shares +7.74%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.64 M USD -95.7%
Research and Development Expense 67 M USD +37%
Costs and Expenses 101 M USD +33.9%
Operating Income (Loss) -101 M USD -33.9%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -106 M USD -45.4%
Earnings Per Share, Basic -4.28 USD/shares +21%
Earnings Per Share, Diluted -4.56 USD/shares +6.94%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 81.3 M USD -16.4%
Cash, Cash Equivalents, and Short-term Investments 110 M USD -0.99%
Assets, Current 118 M USD -1.03%
Property, Plant and Equipment, Net 52 K USD -16.1%
Operating Lease, Right-of-Use Asset 997 K USD -39.4%
Other Assets, Noncurrent 4.58 M USD +12608%
Assets 124 M USD +2.2%
Accounts Payable, Current 7.45 M USD +51.9%
Employee-related Liabilities, Current 2.53 M USD +41.7%
Accrued Liabilities, Current 17.4 M USD +24.7%
Liabilities, Current 26.7 M USD +19.5%
Operating Lease, Liability, Noncurrent 270 K USD -78.4%
Other Liabilities, Noncurrent 51 K USD
Liabilities 77.3 M USD +15.9%
Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value 21.2 M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -4 K USD -167%
Retained Earnings (Accumulated Deficit) -859 M USD -14%
Stockholders' Equity Attributable to Parent 25.1 M USD -24.1%
Liabilities and Equity 124 M USD +2.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.3 M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 846 K USD -98.1%
Net Cash Provided by (Used in) Investing Activities 31 M USD
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 25.3 M shares -87.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.52 M USD -84.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 82.6 M USD -16.4%
Deferred Tax Assets, Valuation Allowance 152 M USD +13.8%
Deferred Tax Assets, Gross 153 M USD +13.6%
Operating Lease, Liability 1.25 M USD -33.7%
Depreciation 6 K USD -80%
Payments to Acquire Property, Plant, and Equipment 21 K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -106 M USD -45.7%
Lessee, Operating Lease, Liability, to be Paid 1.36 M USD -37.1%
Property, Plant and Equipment, Gross 1.63 M USD +0.43%
Operating Lease, Liability, Current 981 K USD +18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.08 M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 546 K USD +2.06%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 108 K USD -60.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.08 M USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 110 M USD +6.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 546 K USD 0%
Operating Lease, Payments 1.07 M USD +2.11%
Preferred Stock, Shares Outstanding 1.2 M shares
Interest Expense 4.5 M USD +57.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%